Nature Medicine and GBEI launch brain health commission

Nature Medicine and the Global Brain Economy Initiative have launched a two-year commission to make brain capital a core part of economic policy. The effort aims to define, measure, and operationalize brain health as a driver of resilience for governments, funders, and multilateral institutions.

Why it matters: - Brain health is being framed as economic infrastructure, not just a clinical issue. - The commission argues that brain capital — the combined value of brain health and brain skills — is still largely unmeasured in policy and economic planning. - Rising costs from brain health disorders and higher cognitive demands in the AI economy make the gap a material risk to long-term prosperity. - The initiative is designed to give governments and global institutions a practical framework for linking brain health to economic resilience.

What happened: - Nature Medicine and the Global Brain Economy Initiative launched the Commission on Brain Health for Economic Resilience on June 10, 2026. - The two-year, transdisciplinary effort will build the scientific evidence base needed to place brain capital at the center of global economic strategy. - The commission brings together experts in neuroscience, economics, epidemiology, public policy, environmental science, and global health. - The work is organized around a central thesis: brain capital is a measurable and modifiable determinant of economic resilience.

The details: - The commission has three core objectives. - It will define the brain economy by mapping the cognitive and emotional capacities most tied to economic performance across health, education, labor, technology, environment, and finance. - It will develop a validated Brain Capital Index as a decision-support tool for governments, funders, and multilateral institutions. - The index builds on the Global Brain Capital Index introduced at the 2026 World Economic Forum Davos Brain House. - It will produce policy playbooks and integration frameworks for governments and organizations including the World Bank, ILO, IMF, OECD, and WHO. - GBEI Executive Director Harris Eyre said global coordination has been missing and said the Nature Medicine Commission’s research agenda will help lay the foundation for a brain economy that supports resilience and human flourishing worldwide. - The commission’s five co-chairs are Harris Eyre, Rym Ayadi, Agustín Ibáñez, Mie Rizig, and Simon Fischer-Baum. - Eyre is a senior fellow at Rice University and The University of Texas Medical Branch. - Ayadi is a professor of banking and finance at City College London, founder and president of EMEA, and a senior advisor at the Center for European Policy Studies. - Ibáñez is director of BrainLat, a full professor at Universidad Adolfo Ibáñez, and a professor at the Global Brain Health Institute at Trinity College Dublin. - Rizig is a clinical senior research fellow at UCL Queen Square Institute of Neurology, University College London. - Fischer-Baum is an associate professor of psychological sciences at Rice University and co-lead of the Rice University Brain and Society Initiative of the Rice Brain Institute. - Founding partners include the Euro-Mediterranean Economists Association, the Institute for Health Metrics and Evaluation, the Brain Economy Action Forum, and Project Metis. - The secretariat is housed at the Global Brain Economy Initiative at Rice University. - The announcement includes a link to the full Nature Medicine Commission on Brain Health for Economic Resilience announcement”}

Between the lines: - The launch signals a push to move brain health from a scientific concern into a macroeconomic policy framework. - The commission is also trying to create a shared measurement language that could make brain capital legible to finance ministries, multilateral lenders, and employers. - The emphasis on an index suggests the group wants the issue to be tracked like other economic indicators, not treated as a niche health topic.

What’s next: - Over the next two years, the commission will publish the evidence base, measurement framework, and policy tools needed to support adoption. - The Brain Capital Index is expected to be refined for use by governments and international institutions. - The group will work on implementation pathways that could bring brain capital into mainstream economic decision-making. - The announcement lists Ellyson Glance of the Global Brain Economy Initiative as a media contact.

The bottom line: - Nature Medicine and GBEI are trying to make brain health measurable, investable, and central to economic resilience.